Assignee
HTG MOLECULAR DIAGNOSTICS INC
US·6 granted patents·6 pending applications·5 citations·filing 2012–2022
Top patents by PatentIndex Score
12 records- 0175US9765385B2Nuclease protection methods for detection of nucleotide variantsHTG MOLECULAR DIAGNOSTICS INC·Filed 2013·Granted Sep 19, 2017·2 cites·20 claims
- 0269US9758829B2Molecular malignancy in melanocytic lesionsHTG MOLECULAR DIAGNOSTICS INC·Filed 2013·Granted Sep 12, 2017·1 cites·13 claims
- 0369US9512469B2Methods of co-detecting MRNA and small non-coding RNAHTG MOLECULAR DIAGNOSTICS INC·Filed 2012·Granted Dec 6, 2016·1 cites·22 claims
- 0466US11384399B2Methods for subtyping diffuse large B-cell lymphoma (DLBCL)HTG MOLECULAR DIAGNOSTICS INC·Filed 2016·Granted Jul 12, 2022·1 cites·33 claims
- 0561US11268133B2Methods of detecting gene fusionsHTG MOLECULAR DIAGNOSTICS INC·Filed 2019·Granted Mar 8, 2022·0 cites·7 claims
- 0657US2014235460A1Quantitative nuclease protection assay (qnpa) and sequencing (qnps) improvementsHTG MOLECULAR DIAGNOSTICS INC·Filed 2014·Application pending·0 cites
- 0754US2024425914A1Epitranscriptome evaluationHTG MOLECULAR DIAGNOSTICS INC·Filed 2022·Application pending·0 cites
- 0847US2016265036A1Methods for detecting nucleic acidsHTG MOLECULAR DIAGNOSTICS INC·Filed 2014·Application pending·0 cites
- 0944US2013288915A1Compositions and methods for alk molecular testingHTG MOLECULAR DIAGNOSTICS INC·Filed 2013·Application pending·0 cites
- 1039US2022106640A1Methods of detecting dna and rna in the same sampleHTG MOLECULAR DIAGNOSTICS INC·Filed 2019·Application pending·0 cites
- 1139US2016019337A1Subtyping lung cancersHTG MOLECULAR DIAGNOSTICS INC·Filed 2014·Application pending·0 cites
- 1230US12104206B2Method of direct target sequencing using nuclease protectionHTG MOLECULAR DIAGNOSTICS INC·Filed 2017·Granted Oct 1, 2024·0 cites·29 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →